Mauripharm Limited - Accounts to registrar (filleted) - small 17.3

REGISTERED NUMBER: 03120490 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2017

FOR

MAURIPHARM LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTOR:

A C Kureeman

SECRETARY:

Ms N Baurhoo

REGISTERED OFFICE:

224 Barnett Wood Lane

Ashstead

Surrey

KT21 2DB

REGISTERED NUMBER:

03120490 (England and Wales)

ACCOUNTANTS:

Buckleys

Chartered Accountants

Unit 3, Shelley Farm

Shelley Lane

Ower

Romsey

Hampshire

SO51 6AS

FIXED ASSETS

Intangible assets

4

6,800

13,600

Tangible assets

5

606,837

630,584

Investments

6

7,863

7,863

621,500

652,047

CURRENT ASSETS

Stocks

87,083

91,074

Debtors

7

318,756

267,375

Cash at bank and in hand

23,950

26,203

429,789

384,652

CREDITORS

Amounts falling due within one year

8

301,473

336,901

NET CURRENT ASSETS

128,316

47,751

TOTAL ASSETS LESS CURRENT LIABILITIES

749,816

699,798

CREDITORS

Amounts falling due after more than one year

9

384,274

442,571

NET ASSETS

365,542

257,227

CAPITAL AND RESERVES

Called up share capital

2

2

Revaluation reserve

10

86,854

86,854

Retained earnings

278,686

170,371

SHAREHOLDERS' FUNDS

365,542

257,227

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2017.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2017 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director on 23 December 2017 and were signed by:

A C Kureeman - Director

1.	STATUTORY INFORMATION

Mauripharm Limited is a private company, limited by shares , registered in England and

Wales. The company's registered number and registered office address can be found on the

Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding

discounts, rebates, value added tax and other sales taxes.

Goodwill

Goodwill, being the amount paid in connection with the acquisition of a business in 0, is being amortised evenly over its estimated useful life of nil years.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets

are measured at cost less any accumulated amortisation and any accumulated impairment

losses.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Freehold property

-

2% on cost

Fixtures and fittings

-

20% on reducing balance

Computer equipment

-

25% on cost

Investments in subsidiaries

Investments in subsidiary undertakings are recognised at cost.

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance

for obsolete and slow moving items.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income

Statement, except to the extent that it relates to items recognised in other comprehensive

income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that

have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not

reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in

periods different from those in which they are recognised in financial statements. Deferred

tax is measured using tax rates and laws that have been enacted or substantively enacted

by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it

is probable that they will be recovered against the reversal of deferred tax liabilities or other

future taxable profits.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the

company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 12 .

4.	INTANGIBLE FIXED ASSETS

Goodwill

£

COST

At 1 April 2016

and 31 March 2017

136,000

AMORTISATION

At 1 April 2016

122,400

Charge for year

6,800

At 31 March 2017

129,200

NET BOOK VALUE

At 31 March 2017

6,800

At 31 March 2016

13,600

5.	TANGIBLE FIXED ASSETS

Fixtures

Freehold

and

Computer

property

fittings

equipment

Totals

£

£

£

£

COST

At 1 April 2016

and 31 March 2017

684,969

116,680

16,116

817,765

DEPRECIATION

At 1 April 2016

90,099

84,598

12,484

187,181

Charge for year

13,699

6,416

3,632

23,747

At 31 March 2017

103,798

91,014

16,116

210,928

NET BOOK VALUE

At 31 March 2017

581,171

25,666

-

606,837

At 31 March 2016

594,870

32,082

3,632

630,584

6.	FIXED ASSET INVESTMENTS

Shares in

group

Other

undertakings

investments

Totals

£

£

£

COST

At 1 April 2016

and 31 March 2017

100

7,763

7,863

NET BOOK VALUE

At 31 March 2017

100

7,763

7,863

At 31 March 2016

100

7,763

7,863

7.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.3.17

31.3.16

£

£

Trade debtors

315,004

263,726

Other debtors

2,920

2,174

Directors' current accounts

832

-

VAT

-

1,475

318,756

267,375

8.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.3.17

31.3.16

£

£

Bank loans and overdrafts

-

6,058

Trade creditors

249,435

266,533

Corporation tax

44,597

39,638

Social security and other taxes

4,235

(650

)

VAT

53

-

Directors' current accounts

-

19,339

Accruals and deferred income

3,153

5,983

301,473

336,901

9.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

31.3.17

31.3.16

£

£

Bank loans more 5 yr by instal

384,274

442,571

Amounts falling due in more than five years:

Repayable by instalments

Bank loans more 5 yr by instal

384,274

442,571

10.

RESERVES

Revaluation

reserve

£

At 1 April 2016

and 31 March 2017

86,854

11.	DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended

31 March 2017 and 31 March 2016:

31.3.17

31.3.16

£

£

A C Kureeman

Balance outstanding at start of year

(19,339

)

(48,135

)

Amounts advanced

100,171

108,796

Amounts repaid

(80,000

)

(80,000

)

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of year

832

(19,339

)